CN1221276C - Compound Huangyangning (Chinese littleleaf box) small pills - Google Patents
Compound Huangyangning (Chinese littleleaf box) small pills Download PDFInfo
- Publication number
- CN1221276C CN1221276C CN 03113001 CN03113001A CN1221276C CN 1221276 C CN1221276 C CN 1221276C CN 03113001 CN03113001 CN 03113001 CN 03113001 A CN03113001 A CN 03113001A CN 1221276 C CN1221276 C CN 1221276C
- Authority
- CN
- China
- Prior art keywords
- buxine
- compound
- effect
- small
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a compound buxine dropping pill for curing angiocardiopathy and cerebrovascular diseases, which is composed of buxine, borneol and medicinal excipient, wherein the dosage ratio of the buxine to the borneol is equal to 1:0.1 to 0.5. in the present invention, the buxine is prepared into a medicine in the preparation form of compound dropping pills which has rapid medicinal effect, high bioavailability and small side effect. The dropping pill of the present invention can increase the stability of medicines, is not easy to oxidize because the medicine has a small contact area with air after merging with a substrate, and has the characteristics of simple production equipment, easy operation, small weight variation, low cost, no powder dust, favorableness of labour protection, etc. The compound buxine dropping pill using buxine as a main raw material, and is mainly used for researches on arrhythmia. Pharmacological experiments verify that the compound buxine dropping pill has better effect than amiodarone tablets and buxine tablets, and has the characteristics of good medicinal curative effect, small toxic and side effect, and obvious effect.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine for the treatment of cardiovascular and cerebrovascular disease, particularly a kind of Chinese patent medicine drop pill.
Background technology
Cardiovascular and cerebrovascular disease is commonly encountered diseases, frequently-occurring disease, and all patients need to adopt Drug therapy.The effective ingredient that the applicant extracts from the natural plants Ramulus Buxi Sinicae---Buxine, a large amount of clinical proofs through more than 20 years, Buxine is resisting myocardial ischemia, is reducing myocardial oxygen consumption, is improving the myocardial ischemia ability, is improving coronary circulation, is dwindling myocardial infarct size, is strengthening myocardial contraction, preventing that aspect such as arrhythmia is evident in efficacy, and toxic and side effects is little.The applicant has been developed into tablet and has been used for clinical.And the Western medicine antiarrhythmic drug is a lot of at present, but the overwhelming majority all has sizable toxic and side effects, is the fatal shortcoming of chemical synthetic drug.
Summary of the invention
Purpose of the present invention is utilized compound preparation exactly, and it is faster to seek a kind of drug effect, and effective percentage is higher, the medicine for treatment that has no side effect---compound drop pills of ' Huangtangning '.
Technical solution of the present invention:
A kind of compound drop pills of ' Huangtangning ' is characterized in that it is made up of Buxine, Borneolum Syntheticum and pharmaceutical excipient, and wherein, the ratio of the weight of Buxine and Borneolum Syntheticum is 1: 0.1-0.5.
The present invention makes the compound dripping pill dosage form with Buxine, and its drug effect performance rapidly, bioavailability is high, side effect is little.Drop pill of the present invention can increase stability of drug, and is less with the air contact area because of after medicine and substrate merges, and is difficult for oxidation, has that production equipment is simple, processing ease, and weight differential is less, and cost is low, and no dust helps characteristics such as labor protection.It is primary raw material that compound drop pills of ' Huangtangning ' is used Buxine, and emphasis carries out primary study to the arrhythmia disease, proves through pharmacological experiment, its effect is better than amiodarone and Buxine tablet, and pharmaceutical effectiveness is good, and toxic and side effects is little, and rapid-action, be the unique distinction of compound drop pills of ' Huangtangning '.
The specific embodiment
Compound drop pills of ' Huangtangning ' of the present invention is made up of Buxine, Borneolum Syntheticum and pharmaceutical excipient, and wherein, the ratio of the consumption of Buxine and Borneolum Syntheticum is Buxine: Borneolum Syntheticum=1: 0.1-0.5.
Embodiment:
The Borneolum Syntheticum powder mix homogeneously of getting 1 gram Buxine powder and 0.1 gram adds in the pharmaceutical excipient (as Macrogol 4000), and the pill technology can make about 1000 compound drop pills of ' Huangtangning ' routinely.
Perhaps, the Borneolum Syntheticum powder mix homogeneously of getting 1 gram Buxine powder and 0.3 gram or 0.5 gram adds in the pharmaceutical excipient (as Macrogol 4000), and the pill technology also can make about 1000 compound drop pills of ' Huangtangning ' routinely.
Through modern pharmacology proof Borneolum Syntheticum experimental myocardial infarction there is decreased heart rate, improves the effect of coronary flow and reduction myocardial oxygen consumption, and certain sedation and gentle analgesic effect are arranged.On traditional Chinese medical science angle, Borneolum Syntheticum is the merit that " minister " helps " monarch " medicine, can directly go into thinking by priming, gets very speed of effect and make, and the mind must be pacified.The present invention plays promoting flow of QI and blood altogether with the mutual compatibility of two medicines, and the merit of the mind calming of having one's ideas straightened out makes heart ruton smooth, and the disease of cardiopalmus, irregularly intermittent and regularly intermittent pulse can be separated.
Claims (1)
1, a kind of compound drop pills of ' Huangtangning ' is characterized in that it is made up of Buxine, Borneolum Syntheticum and pharmaceutical excipient, and wherein, the ratio of the weight of Buxine and Borneolum Syntheticum is 1: 0.1-0.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03113001 CN1221276C (en) | 2003-03-19 | 2003-03-19 | Compound Huangyangning (Chinese littleleaf box) small pills |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03113001 CN1221276C (en) | 2003-03-19 | 2003-03-19 | Compound Huangyangning (Chinese littleleaf box) small pills |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1438011A CN1438011A (en) | 2003-08-27 |
| CN1221276C true CN1221276C (en) | 2005-10-05 |
Family
ID=27674025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03113001 Expired - Fee Related CN1221276C (en) | 2003-03-19 | 2003-03-19 | Compound Huangyangning (Chinese littleleaf box) small pills |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1221276C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872074B (en) * | 2005-06-01 | 2010-12-01 | 天津天士力制药股份有限公司 | Compound drop pills of 'Huangtangning', and preparation method |
| CN102389434B (en) * | 2011-09-28 | 2013-02-13 | 广州中医药大学 | Medicinal composition for treating ischemic cerebrovascular disease, and preparation method thereof |
-
2003
- 2003-03-19 CN CN 03113001 patent/CN1221276C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1438011A (en) | 2003-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1221276C (en) | Compound Huangyangning (Chinese littleleaf box) small pills | |
| CN1857502A (en) | Chinese medicine liniment for treating toothache and its preparing method | |
| CN101297900A (en) | Medicine new purpose of Ampelopsis Sinica stem leaf total flavones and single component myricetin | |
| CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
| CN1261130C (en) | Medicine for dispelling tinea | |
| CN1296087C (en) | Compound capsule for treating apoplexy involving the meridians of wind phlegm stasis blockage syndrome type and preparation process thereof | |
| CN1278727C (en) | Colonitis enteroclysm | |
| CN1424066A (en) | Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof | |
| CN110755580A (en) | Traditional Chinese medicine composition with analgesic effect and application thereof | |
| CN1470268A (en) | Compound Longxue scorpion and preparation method thereof | |
| CN107596088A (en) | A kind of Chinese medicine for treating lichen planus of mouth | |
| CN1366948A (en) | Nano Fufang Fufangteng preparation medicine and preparation method | |
| CN1094620A (en) | The Chinese patent medicine Liu Hua ai huixiangdan of the treatment esophageal carcinoma | |
| CN1850177A (en) | Method for preparing micropill capsule of salvia miltiorrhiza bge, and gynostemma pentaphyllum, and its use | |
| CN100344288C (en) | Compound pain-stopping and inflammation-diminishing anticarcinogen capsule | |
| CN1511540A (en) | Use of scutellarin in preparing medicine for treating or preventing stomatocace | |
| CN1362147A (en) | Nano mixed red sage medicine and its preparation | |
| CN1208630A (en) | Traditional Chinese medicine series used for anticancer and method for preparing same | |
| CN1362191A (en) | Nano Folium Ginkgo medicine and its preparation | |
| CN102258554A (en) | New medicine for treating senile dementia | |
| CN1362198A (en) | Nano Chinese angelica medicine and its preparation | |
| CN1362171A (en) | Nano notoginseng medicine and its preparation | |
| CN1154847A (en) | Series medicinal preparation for treating cancer and production method thereof | |
| CN1733027A (en) | Cold-treating oral liquid and preparation process thereof | |
| CN1080858A (en) | Compound Radix Scutellariae granules and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: NANJING XIAOYING MEDICINE GROUP CO.,LTD. Free format text: FORMER NAME: NANJING XIAOYING PHARMACEUTICAL FACTORY |
|
| CP03 | Change of name, title or address |
Address after: No. 18, Shun Fa Road, Dongshan high tech Industrial Zone, Nanjing, Jiangsu, Jiangning Patentee after: Nanjing Xiaoying Pharmaceutical Group Co. Ltd. Address before: Nanjing City, Jiangsu province Longpan Road No. 29 Patentee before: Nanjing Xiaoying pharmaceutical factory |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051005 Termination date: 20120319 |